Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Aspen Aerogels Inc. (NYSE: ASPN) was $15.22 for the day, down -2.81% from the previous closing price of $15.66. In other words, the price has decreased by -$2.81 from its previous closing price. On the day, 0.97 million shares were traded. ASPN stock price reached its highest trading level at $16.06 during the session, while it also had its lowest trading level at $14.92.
Ratios:
Our analysis of ASPN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.91 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $22.
On March 20, 2023, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 20 ’23 when Landes Gregg sold 155 shares for $11.01 per share. The transaction valued at 1,707 led to the insider holds 126,393 shares of the business.
Mitchell Steven R bought 7,541 shares of ASPN for $49,009 on Sep 07 ’23. The Director now owns 134,260 shares after completing the transaction at $6.50 per share. On Sep 05 ’23, another insider, Mitchell Steven R, who serves as the Director of the company, bought 50,000 shares for $6.17 each. As a result, the insider paid 308,455 and bolstered with 126,719 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASPN now has a Market Capitalization of 1168319104 and an Enterprise Value of 1165883136. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.89 while its Price-to-Book (P/B) ratio in mrq is 2.39. Its current Enterprise Value per Revenue stands at 4.884 whereas that against EBITDA is -34.407.
Stock Price History:
The Beta on a monthly basis for ASPN is 1.97, which has changed by 1.0567567 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, ASPN has reached a high of $19.10, while it has fallen to a 52-week low of $5.32. The 50-Day Moving Average of the stock is -7.41%, while the 200-Day Moving Average is calculated to be 33.67%.
Shares Statistics:
ASPN traded an average of 985.24K shares per day over the past three months and 651250 shares per day over the past ten days. A total of 76.50M shares are outstanding, with a floating share count of 75.18M. Insiders hold about 1.94% of the company’s shares, while institutions hold 97.90% stake in the company. Shares short for ASPN as of 1713139200 were 4815237 with a Short Ratio of 4.89, compared to 1710460800 on 4783481. Therefore, it implies a Short% of Shares Outstanding of 4815237 and a Short% of Float of 8.61.
Earnings Estimates
The market rating of Aspen Aerogels Inc. (ASPN) is currently shaped by the ongoing analysis conducted by 9.0 analysts closely monitoring its performance.On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.02 and a low estimate of -$0.17, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.02 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.08 and -$0.31 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is $0.66, with 8.0 analysts recommending between $1.36 and $0.3.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 9 analysts. It ranges from a high estimate of $87.5M to a low estimate of $58.66M. As of the current estimate, Aspen Aerogels Inc.’s year-ago sales were $45.14MFor the next quarter, 9 analysts are estimating revenue of $83.94M. There is a high estimate of $91.39M for the next quarter, whereas the lowest estimate is $72.23M.
A total of 9 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $403.41M, while the lowest revenue estimate was $348.94M, resulting in an average revenue estimate of $362.02M. In the same quarter a year ago, actual revenue was $238.72MBased on 8 analysts’ estimates, the company’s revenue will be $573.82M in the next fiscal year. The high estimate is $674.74M and the low estimate is $513M.
